BackOcean Biomedical - Warrants (14/02/2028) Overview
Ocean Biomedical Inc. - Warrants (14/02/2028)

Ocean Biomedical - Warrants (14/02/2028) Return on Equity

Latest ROE for Ocean Biomedical - Warrants (14/02/2028): 26.56% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

26.56%

Return on Equity

26.56%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Ocean Biomedical - Warrants (14/02/2028) (OCEAW) FAQ

The latest ROE for OCEAW is 26.56%. That is above the sector sector average of -4.47%. Investors often review this figure alongside Ocean Biomedical - Warrants (14/02/2028)'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, OCEAW currently prints 26.56% for ROE, while the sector average sits near -4.47%. That is roughly 694.4% above the sector mean. Large gaps often invite a closer look at Ocean Biomedical - Warrants (14/02/2028)'s growth, margins, and balance sheet.

Return on Equity shows how effectively Ocean Biomedical - Warrants (14/02/2028) converts resources into returns. At 26.56%, OCEAW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting OCEAW's ROE (26.56%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.